Hyperthermia Combined with Immune-Modulation in Cancer Therapy
Today’s strategies for treatment of neoplastic disease, including extensive surgery, chemotherapy and radiotherapy, alone or in combination, have given acceptable results in a limited number of tumors. However, the results obtained in over thirty years with these methods cannot be considered satisfactory in the large majority of malignant tumors.
KeywordsCoryne Bacterium Extensive Surgery Neoplastic Tissue Immune Stimulation Thymic Hormone
Unable to display preview. Download preview PDF.
- 1.US National Centre for Health Statistics and US Bureau of the Census.Google Scholar
- 2.L. A. Shafer, M. L. Washington, A. L. Golstein, Thymosin immunotherapy. A phase I study, Am. Soc. Clin. Oncol. 16:233 (1975)Google Scholar
- 3.M. W. Dewhirst, W. G. Connor, T. E. Moon, Evaluation of the heat, radiation and heat and radiation response of spontaneous large animal tumors: preliminary results of a phase IH randomized trial, The Third International Symposium Cancer Therapy by Hyperthermia, Drugs and Radiation, Colorado (1980).Google Scholar
- 5.H. H. LeVeen, “Radiofrequency in the treatment of malignant tumors. Radiotherapy and Oncology,” T. J. Deeley ed., Volume II, Wright PSG, Bristol (1982).Google Scholar
- 6.P. Pontiggia, H. H. LeVeen, G. L. Ganzetti, La termoterapia localizzata nella cura dei tumori maligni. Valutazione clinica preliminare, Rec. Progr. Med. 70:5 (1981).Google Scholar